PolyPid (PYPD)
(Delayed Data from NSDQ)
$4.60 USD
-0.10 (-2.13%)
Updated Mar 28, 2024 10:16 AM ET
After-Market: $4.95 +0.35 (7.61%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Brokerage Reports
0 items in cart
PolyPid Ltd. [PYPD]
Reports for Purchase
Showing records 1 - 4 ( 4 total )
Company: PolyPid Ltd.
Industry: Medical - Drugs
SHIELD II Enrollment Milestone; 2023 Financials; Lowering PT to $14
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
SHIELD II Phase 3 Trial Advancing; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
Solving Surgical Site Infections; Initiating at Buy and $16 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: PolyPid Ltd.
Industry: Medical - Drugs
|